HCK and malignant colon neoplasm: Likewise, Poh et al. [196, 197] demonstrated that inhibition of hematopoietic cell kinase (HCK) reduced alternative activation of TAMs and also attenuated the growth of colon cancer xenografts along with enhancement of immunotherapy, since high HCK expression correlates with a reduced survival of colorectal cancer patients.